Vietnamese (HOSE) Pharma Industry Analysis
UpdatedNov 27, 2023
DataAggregated Company Financials
Companies19
- 7D-1.2%
- 3M-7.6%
- 1Y21.1%
- YTD13.0%
Over the last 7 days, the Pharma industry has dropped 1.2%, driven by DHG Pharmaceutical declining 1.3%. Over the past 12 months, the industry was up 21%. Looking forward, earnings are forecast to grow by 13% annually.
Industry Valuation and Performance
Has the Vietnamese Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 27 Nov 2023 | ₫36.1t | ₫18.4t | ₫2.4t | 13.5x | 14.9x | 2x |
| Wed, 25 Oct 2023 | ₫37.8t | ₫16.9t | ₫2.4t | 13.7x | 15.9x | 2.2x |
| Fri, 22 Sep 2023 | ₫39.8t | ₫16.9t | ₫2.4t | 13.6x | 16.4x | 2.4x |
| Sun, 20 Aug 2023 | ₫38.3t | ₫16.9t | ₫2.4t | 13x | 15.7x | 2.3x |
| Tue, 18 Jul 2023 | ₫40.5t | ₫16.7t | ₫2.3t | 14.7x | 17.3x | 2.4x |
| Thu, 15 Jun 2023 | ₫38.6t | ₫16.7t | ₫2.3t | 14x | 16.5x | 2.3x |
| Sat, 13 May 2023 | ₫34.6t | ₫16.7t | ₫2.3t | 13.1x | 14.8x | 2.1x |
| Mon, 10 Apr 2023 | ₫31.2t | ₫18.2t | ₫2.4t | 12.3x | 13.2x | 1.7x |
| Wed, 08 Mar 2023 | ₫32.2t | ₫18.2t | ₫2.4t | 12x | 13.4x | 1.8x |
| Fri, 03 Feb 2023 | ₫32.2t | ₫18.1t | ₫2.4t | 12.5x | 13.7x | 1.8x |
| Sun, 01 Jan 2023 | ₫31.3t | ₫17.3t | ₫2.3t | 12.4x | 13.9x | 1.8x |
| Tue, 29 Nov 2022 | ₫30.2t | ₫17.3t | ₫2.3t | 12.8x | 13.4x | 1.8x |
| Thu, 27 Oct 2022 | ₫31.1t | ₫17.3t | ₫2.2t | 13.2x | 14x | 1.8x |
| Sat, 24 Sep 2022 | ₫32.5t | ₫16.6t | ₫2.1t | 15.5x | 15.6x | 2x |
| Mon, 22 Aug 2022 | ₫33.3t | ₫16.6t | ₫2.1t | 14.7x | 16.1x | 2x |
| Wed, 20 Jul 2022 | ₫31.7t | ₫16.3t | ₫2.0t | 14.7x | 15.9x | 1.9x |
| Fri, 17 Jun 2022 | ₫32.6t | ₫16.3t | ₫2.0t | 16x | 16.3x | 2x |
| Sun, 15 May 2022 | ₫32.9t | ₫16.3t | ₫2.0t | 16x | 16.4x | 2x |
| Tue, 12 Apr 2022 | ₫37.8t | ₫15.9t | ₫1.9t | 18.6x | 19.6x | 2.4x |
| Thu, 10 Mar 2022 | ₫43.7t | ₫18.4t | ₫2.3t | 16.5x | 18.9x | 2.4x |
| Sat, 05 Feb 2022 | ₫41.5t | ₫18.4t | ₫2.3t | 16.1x | 18x | 2.3x |
| Mon, 03 Jan 2022 | ₫43.2t | ₫18.0t | ₫2.3t | 16.9x | 18.8x | 2.4x |
| Wed, 01 Dec 2021 | ₫42.0t | ₫18.8t | ₫2.3t | 17.2x | 18.2x | 2.2x |
| Fri, 29 Oct 2021 | ₫41.2t | ₫18.4t | ₫2.3t | 17x | 18x | 2.2x |
| Sun, 26 Sep 2021 | ₫41.4t | ₫18.7t | ₫2.3t | 16.5x | 18.3x | 2.2x |
| Tue, 24 Aug 2021 | ₫39.3t | ₫18.7t | ₫2.3t | 16.3x | 17.3x | 2.1x |
| Wed, 30 Jun 2021 | ₫40.1t | ₫18.7t | ₫2.3t | 14.5x | 17.7x | 2.1x |
| Sat, 03 Apr 2021 | ₫39.0t | ₫18.1t | ₫2.2t | 16.1x | 17.7x | 2.2x |
| Tue, 05 Jan 2021 | ₫37.5t | ₫18.0t | ₫2.2t | 16.1x | 17.3x | 2.1x |
Price to Earnings Ratio
16.6x
Current Industry PE
- Investors are relatively neutral on the Vietnamese Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 16.5x.
- The industry is trading close to its 3-year average PS ratio of 2.1x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have grown 3.7% per year over the last three years, while revenues have remained mostly flat.
- This means that companies overall are more efficiently conducting business since profits are increasing while sales have been flat.
Industry Comparison
How does Vietnamese Pharma compare with similar industries?
| VN Market | -0.53% | |
| Healthcare | -1.31% | |
| Pharma | -1.24% | |
| Pharma | -1.24% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| DHT Ha Tay Pharmaceutical JSC | ₫23.10k | 0.9% +₫14.8b | 63.7% | PE21.6x | |
| DBT Ben Tre Pharmaceutical | ₫12.35k | 3.8% +₫7.3b | 20.2% | n/a | |
| DVM Vietnam Medicinal Materials | ₫13.10k | 1.6% +₫7.1b | -3.7% | n/a | |
| DP3 Central Pharmaceutical No3 | ₫64.20k | 0.3% +₫4.3b | 78.3% | PE12x | |
| PPP Phong Phu Pharmaceutical | ₫14.50k | 2.8% +₫3.5b | 16.0% | PE6.8x |